These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
776 related articles for article (PubMed ID: 20526972)
1. The perverse consequences of a proposed global tax on research. MacDonald C; Walton N Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972 [No Abstract] [Full Text] [Related]
2. Human rights: the normative engine of fairness and research in developing countries. McMillan J Am J Bioeth; 2010 Jun; 10(6):47-9. PubMed ID: 20526973 [No Abstract] [Full Text] [Related]
3. Justice in the application of science: beyond fair benefits. London AJ Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976 [No Abstract] [Full Text] [Related]
4. Response to open peer commentaries on "How to do research fairly in an unjust world". Ballantyne AJ Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959 [No Abstract] [Full Text] [Related]
5. Practical and political problems with a global research tax. Resnik DB Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971 [No Abstract] [Full Text] [Related]
6. For-profit clinical trials in developing countries--those troublesome patient benefits. Schuklenk U Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975 [No Abstract] [Full Text] [Related]
7. Why adopt a maximin theory of exploitation? Wertheimer A; Millum J; Schaefer GO Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968 [No Abstract] [Full Text] [Related]
8. How to do research fairly in an unjust world. Ballantyne AJ Am J Bioeth; 2010 Jun; 10(6):26-35. PubMed ID: 20526966 [TBL] [Abstract][Full Text] [Related]
9. Multiple forms of exploitation in international research: the need for multiple standards of fairness. Snyder J Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969 [No Abstract] [Full Text] [Related]
10. International research and positive obligations: are they "transaction specific"? Rossi J Am J Bioeth; 2010 Jun; 10(6):49-51. PubMed ID: 20526974 [No Abstract] [Full Text] [Related]
11. Fair benefits in developing countries: maximin as a good start. Macklin R Am J Bioeth; 2010 Jun; 10(6):36-7. PubMed ID: 20526967 [No Abstract] [Full Text] [Related]
12. One size does not fit all: toward "upstream ethics"? Ozdemir V; Knoppers BM Am J Bioeth; 2010 Jun; 10(6):42-4. PubMed ID: 20526970 [No Abstract] [Full Text] [Related]
13. Undue inducement: nonsense on stilts? Emanuel EJ Am J Bioeth; 2005; 5(5):9-13; discussion W8-11, W17. PubMed ID: 16179296 [No Abstract] [Full Text] [Related]
14. A quartet of criticisms. Vanderpool HY Am J Bioeth; 2005; 5(5):16-9. PubMed ID: 16179299 [No Abstract] [Full Text] [Related]
15. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
16. How not to rethink research ethics. Beauchamp TL Am J Bioeth; 2005; 5(1):31-3; author reply W15-8. PubMed ID: 16036653 [No Abstract] [Full Text] [Related]
18. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits. Farrell K J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228 [No Abstract] [Full Text] [Related]
20. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related] [Next] [New Search]